Addgene is launching the service with more than 27,000 plasmids available in the Transfection-Ready format across three of the most-requested areas of its collection: CRISPR, imaging and reporters, ...
Collaboration with NCI's Cancer Therapy Evaluation Program (CTEP) will evaluate IMNN-001in new indications and combination regimensIMUNON retains ...
IMUNON Inc. ( IMNN ), a clinical-stage biotechnology company developing DNA-mediated immunotherapies, announced it has entered into a Cooperative Research and Development Agreement (CRADA) with the ...
The "DNA and Gene Cloning Services - Market Insights, Competitive Landscape, Forecast - 2034" has been added to ResearchAndMarkets.com's offering. The global DNA and gene cloning services market was ...
September 11, 2026) - On August 4, the 20th Frost & Sullivan Global Growth, Innovation and Leadership (GIL) Summit and the 5th New Investment Event (the "2026 Frost & Sullivan New Investment Event") ...
As one notable company exits the field, growing CDMOs open facilities and secure major contracts ...
AI can rapidly generate new protein binders, but wet-lab validation remains a major bottleneck. Combining cell-free protein ...
IMUNON partners with National Cancer Institute to advance IMNN-001 IL-12 immunotherapy beyond ovarian cancer. NCI assumes ...
CDMO company Northway Biotech has opened a €61 million cell therapy and personalized medicine center in Vilnius that is being ...
A report from ResearchandMarkets.com explores why the chromatography consumables market is projected to grow more than 50% ...
The authors highlight three potential regulators - galectin 1, galectin 3, and Myc - providing solid evidence for potential roles in modulating the proliferation of cochlear GER cells using gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results